~~<i id='7B34B3372F'><strike id='7B34B3372F'><tt id='7B34B3372F'><pre id='7B34B3372F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

leisure time

author：Wikipedia 2025-09-27 10:00:04 - browse：5366

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

knowledge

focus

entertainment

knowledge

focus

entertainment

AdobeAsofJan.1,thousandsofasthmapatientsintheU.S.willnolongerbeabletogetrefillsforFlovent—oneofthemo

WSS

JPM: CVS says Medicare Advantage patients are impacting profits

Morgan Health, with ambitious aims, wants you to know it’s still here

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Federal weight loss drug coverage is 30 years out of date

NIH tests clinical research in primary care with $30 million program

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

entertainment

leisure time

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Trump demands the U.S. pay no more for drugs than other countries … again

Coercive sterilizations revealed by STAT prompt outrage

DIEP, the 'gold standard' of breast reconstruction, is under threat

Curing rare childhood diseases will falter unless Congress steps up

How to save PrEP access — and even expand it

Antibiotic resistance and the global rise in human conflict

Medicare proposal to cover medical devices draws a mixed reaction

3 medical device trends to watch in 2024

focus

The biotech scorecard for Q1: 17 stock

White House finalizes ITC's import ban of latest Apple Watches

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Study: Why relieving medical debt did not improve financial outcomes

Stephen Quake on the Chan Zuckerberg quest to conquer disease

New report analyzes digital physical therapy solutions' effectiveness

entertainment

knowledge

focus

entertainment